An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma/Experiment 2/Signature 2
From BugSigDB
Reviewed Marked as Reviewed by Claregrieve1 on 2023-5-23
Source: Figure 3b
Description: Differential microbial abundance in baseline gut microbiome between patients whose disease was not controlled and patients whose disease was controlled
Abundance in Group 1: decreased abundance in Disease control with Immune checkpoint inhibitors
| NCBI | Quality Control | Links |
|---|---|---|
| Faecalibacterium |
Revision editor(s): Mary Bearkland, Claregrieve1
